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https://doi.org/10.1016/j.cell.2021.08.014SUMMARYWe present evidence for multiple independent origins of recombinant SARS-CoV-2 viruses sampled from
late 2020 and early 2021 in the United Kingdom. Their genomes carry single-nucleotide polymorphisms and
deletions that are characteristic of the B.1.1.7 variant of concern but lack the full complement of lineage-
defining mutations. Instead, the remainder of their genomes share contiguous genetic variation with
non-B.1.1.7 viruses circulating in the same geographic area at the same time as the recombinants. In
four instances, there was evidence for onward transmission of a recombinant-origin virus, including one
transmission cluster of 45 sequenced cases over the course of 2 months. The inferred genomic locations
of recombination breakpoints suggest that every community-transmitted recombinant virus inherited its
spike region from a B.1.1.7 parental virus, consistent with a transmission advantage for B.1.1.7’s set of
mutations.INTRODUCTION
Recombination, the transfer of genetic information betweenmol-
ecules derived from different organisms, is a fundamental pro-
cess in evolution, because it can generate novel genetic variation
upon which selection can act (Felsenstein, 1974). Genetic anal-
ysis indicates that recombination occurs frequently in betacoro-
naviruses (Lai et al., 1985; Keck et al., 1988; Lai and Cavanagh,
1997), including natural populations of MERS-CoV (Corman
et al., 2014; Dudas and Rambaut, 2016; Kim et al., 2016) and
SARS and SARS-like coronaviruses (Hon et al., 2008; Boni
et al., 2020). The zoonotic transmission of an alphacoronavirus
whose spike gene shows evidence of being the product of
recombination between feline and canine coronaviruses has
occurred in Malaysia, which demonstrates the potential for coro-
navirus recombination associated with host reservoirs (Vlasova
et al., 2021). It has been proposed recently that the global
SARS-CoV-2 genome sequence data contain signals of recom-Cell 184, 5179–5188, Septem
This is an open access article undbination across the pandemic (VanInsberghe et al., 2021).
Recombination has the potential to be important in the context
of pathogen evolution, because it can ‘‘rescue’’ genomes with
otherwise deleterious mutations or provide the opportunity to
create novel phenotypes by bringing genetic variation from
different backgrounds onto a single genome. A concerning sce-
nario from an epidemiological perspective is the potential for
recombination to combine, in the same genome, mutations
that may confer immune-escape properties with those that
may enhance transmissibility. Enhanced transmissibility (Volz
et al., 2021) and immune-escape (Planas et al., 2021) pheno-
types have already been observed in SARS-CoV-2. Conse-
quently, the characterization of recombination in SARS-CoV-2
is important for surveillance purposes.
The molecular mechanism of homologous recombination in
unsegmented positive-sense RNA viruses such as SARS-CoV-
2 is generally by copy-choice replication, amodel first suggested
in poliovirus (Copper et al., 1974). In this process, a hybrid orber 30, 2021 ª 2021 The Authors. Published by Elsevier Inc. 5179
er the CC BY license (http://creativecommons.org/licenses/by/4.0/).
Figure 1. SARS-CoV-2 lineages in the UK, winter 2020–2021
The distribution of the most frequent SARS-CoV-2 lineages in the UK from December 2020 to February 2021. Here, B.1.177 refers to B.1.177, including all of its
descendant lineages (e.g., B.1.177.9). For each recombinant or recombinant group, the date of the earliest sampled genome is indicated by an arrowhead. The
recombination event that generated each must have occurred before this date. For groups A–D, the body of the arrow represents the range of dates that the
samples span.
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OPEN ACCESS Articlemosaic RNA is formed when the RNA-polymerase complex
switches from one RNA template molecule to another during
replication (Worobey and Holmes, 1999). In order for homolo-
gous recombination to occur and be subsequently detected,
there must be coinfection of the same cell within an individual
by genetically distinct viruses (termed the ‘‘parental’’ lineages
of the recombinant virus). Coinfection of an individual requires
there to be co-circulation of multiple viral lineages within a pop-
ulation and, given the short duration of most SARS-CoV-2 infec-
tions, is most likely to be observed when virus prevalence is high.
Conditions conducive to SARS-CoV-2 recombination existed
in the United Kingdom (UK) during the latter part of 2020 and
early in 2021. From mid-October 2020 to January 2021, SARS-
CoV-2 prevalence was estimated to be between 1% and 2% in
England (Steel and Hill, 2021). During this time, the B.1.1.7
variant of concern (VOC), which is also referred to as alpha under
the World Health Organization nomenclature (WHO (World
Health Organization), 2021), emerged, rapidly increased in fre-
quency, and spread across the UK, replacing lineages that
were already at high prevalence (Volz et al., 2021). The most
common of the latter was the B.1.177 lineage and its descen-
dants (Hodcroft et al., 2021) (Figure 1). B.1.1.7 is characterized
by an unusually large number of genetic changes (22 mutations
from its immediate ancestor; (Rambaut et al., 2020b)). The ability
to detect virus recombination using comparative sequence anal-
ysis depends on the genetic distinctiveness of the parental vi-
ruses, so the co-circulation of B.1.1.7 and non-B.1.1.7 viruses
is expected to increase the power to detect recombinants be-
tween these lineages. TheUK’s high rate of genomic surveillance
and unified collection of genomic, epidemiological, and
geographic data also provide multiple lines of evidence for eval-
uating the identification of recombinant viruses.
To identify putative SARS-CoV-2 recombinant viruses, we car-
ried out an analysis of all complete UK SARS-CoV-2 genomes
that had been assigned to lineage B.1.1.7 and that showed evi-
dence of being the product of combining different genetic line-
ages, indicative of recombination. Specifically, we scanned the
UK dataset for genomes that were alternately composed of
long contiguous tracts of B.1.1.7 and non-B.1.1.7 genetic varia-
tion. The genetic composition and epidemiological context of5180 Cell 184, 5179–5188, September 30, 2021each candidate mosaic genome was carefully explored to deter-
mine whether it was recombinant in origin. We subsequently
determined whether the recombinants showed evidence of on-
ward transmission within the UK population. One recombinant
lineage continued to circulate for at least 9 weeks and, as of
May 5, 2021, was associated with 45 linked infections.
RESULTS
Identification of putative recombinants
We identified a total of 16 recombinant sequences from the
whole UK dataset of 279,000 sequences up toMarch 7, 2021 us-
ing our bioinformatic and evolutionary analysis pipeline (see
STAR Methods). Twelve genome sequences that clustered into
four groups (labeled A–D), and four additional singletons showed
evidence of being mosaic in structure (Table 1; Table S1). For
each group A–D, each of the constituent genomes was sampled
from the same geographic locality within the UK (Table 1). For
group A, which spanned two geographical regions, all the sam-
ples originated from close to the border between Wales and
NorthWest England (<20 km apart). The sample dates for the pu-
tative recombinants ranged from December 18, 2020 to
February 2, 2021 (Figure 1). If groups A–D represent community
transmission of a recombinant lineage with a single origin,
recombination must have occurred on or before the date of the
earliest sample in each group. It is possible to use molecular
clock dating to infer bounds on recombination events, but given
uncertainties in the rate of the molecular clock, estimates from
such methods have large confidence intervals (Raghwani et al.,
2012). Because our dataset consists of high-density genomic
sampling covering the time period over which we infer recombi-
nation to have occurred, we use the earliest sample dates
described above as representative of the approximate time of
the recombination events. The range of dates coincides with a
period of increasing relative prevalence of B.1.1.7 in the UK
alongside the presence of other circulating lineages in the com-
munity, themost common of whichwere B.1.177 and its descen-
dants (Figure 1).
To rule out the possibility that any of the 16 recombinants
could have resulted from artifacts as a result of assembling
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1 Scotland 2021/01/17 B.1.177.9 2021/01/13 Greater London 6,954–10,870
The first parental lineage is always B.1.1.7. For the recombinant groups, the number of genomes, the NUTS1 location of residence, and the range of
sampling dates are given. Breakpoint coordinates are the range of possible SARS-CoV-2 genome positions bounded by mutations that are unambig-
uously inherited from one parent or the other, including both single-nucleotide polymorphisms and deletions. The date and location for the second
parent is for the genetically most similar UK genome(s) within the genome region belonging to that lineage.
aFor group A, the results for LIVE-DFCFFE (in parentheses) were different from those of the rest of the group.
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OPEN ACCESSArticlesequence reads from a co-infected sample (generated through
either natural coinfection or laboratory contamination), we exam-
ined the read coverage and minor allele frequencies and
assessed the likelihood of a mixed sample. Several lines of evi-
dence suggested the recombinant sequences were not the
products of sequencing a mixture of genomes. First, the
sequencing protocol used in the UK (Tyson et al., 2020) gener-
ates 98 short (350-bp) amplicons, such that long tracts that
match just one lineage would be unlikely. Second, the read
data do not support amixture for any of the putative recombinant
genomes. All the recombinants were sequenced to high
coverage (lowest mean read depth per site per genome: 686;
highest mean read depth: 2,903). The mean minor allele fre-
quency (MAF) for the putative recombinants was 0.008, which
is 6 standard deviations below the mean of the MAF (0.34) for
a set of 20 sequences that we suspected to be mixtures (Fig-
ure S1). Finally, for all groups A–D, multiple genomes with the
same mosaic structure were sequenced independently from
different samples, and by different sequencing centers in the
case of group A, implying that the original assembly was correct
and, additionally, that transmission of the recombinant had
occurred. All of the read data are available on the European
Nucleotide Archive. Accession numbers are given in Table S2.
Epidemiological information supports the identification
of putative parental lineages
The nucleotide variation for the putative recombinants and their
closest neighbors by genetic similarity (for each of the regions of
their genomes either side of the recombination breakpoint) is
shown in Figures 2 and S2. For each of groups A–D, the closest
neighbors by genetic similarity for each of the two non-recom-bining genome regions were the same sequences for every pu-
tative recombinant within a group. For most of the recombinants,
there were several equidistant putative parental sequences for
each region of the genome; whenever this was true, they all be-
longed to the same lineage, except for group C, whose putative
parental lineages for the non-B.1.1.7-like region of the genome
were a mixture of two closely related lineages (B.1.221.1 and
B.1.221.2). The putative parental sequence for the non-B.1.1.7
region of the genome varied by group (Table 1). Importantly, in
each case, the sequence and epidemiological data demonstrate
that the non-B.1.1.7 parental sequence was circulating in the
same geographic area as the recombinant in the time immedi-
ately before the sampling date of the recombinant. For group A
and the four singletons, the second parental sequence was as-
signed lineage B.1.177 or one of its descendants. B.1.177, which
likely arose in Spain in the summer of 2020 and was exported to
multiple European countries (Hodcroft et al., 2021), rose to high
relative frequency in the UK through autumn 2020 and was wide-
spread by December (Figure 1). Lineage B.1.177.16, the second
parental sequence of MILK-103C712, was sampled 25 times in
Greater London in the 4 weeks precedingMILK-103C712’s sam-
ple date. Lineage B.1.177.9 was sampled on one other occasion
in Scotland in 4 weeks preceding QEUH-1067DEF’s sample
date. Lineage B.1.36.28 was not sampled in South East England
in the 4 weeks preceding group B’s sample date but was
sampled eight times in Greater London in that period. Lineages
B.1.221.1 and B.1.221.2 were sampled seven and zero times,
respectively, in the East Midlands in the 4 weeks preceding
group C’s sample date, and B.1.36.17 was sampled five times
in the South East in the 4 weeks prior to group D’s sample
date. The distributions of the most prevalent lineages in eachCell 184, 5179–5188, September 30, 2021 5181
Figure 2. The nucleotide variation present in group A
The nucleotide variation with respect to the reference sequence (MN908947.3; gray genome, far bottom) for the four members of group A (ALDP-11CF93B,
ALDP-125C4D7, LIVE-DFCFFE, and ALDP-130BB95; middle four colored genomes) and their closest neighbors by genetic similarity among all UK sequences
from the same time period for the B.1.1.7-like region of their genomes (ALPD-12A277F; top colored genome) and the B.1.177-like region of their genomes (ALDP-
119C5F7; bottom colored genome). See also Figure S2.
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OPEN ACCESS Articleregion of the UK relevant to the eight sets of recombinants
(groups A–D and the four singletons) for the 4weeks immediately
preceding the date of the earliest sampled genome in each case
are shown in Figure S3.
Putative recombinants exhibit significant mosaicism
We rejected the null hypothesis of non-reticulate evolution for 14
out of the 16 putative recombinant sequences by testing these
sequences for mosaicism (3SEQ; Lam et al., 2018; with Dunn-Si-
dak correction for multiple comparisons) against a background
set of 2,000 sequences randomly drawn from the course of the
UK epidemic (Table 2). The lineages identified as the putative
parentals assigned by 3SEQ agreed with the lineages for puta-
tive parentals assigned by genetic similarity (Tables 1 and 2),
even though of the 16 closest neighbors by genetic similarity
described above, none were present in the background
sequence set of candidate parentals used in the 3SEQ analysis.
The breakpoints reported by 3SEQ also agreed with breakpoints
inferred from the distribution of single-nucleotide polymor-
phisms (SNPs) and deletions in the putative recombinants and
their neighbors by genetic similarity (Tables 1 and 2). The two se-
quences that belong to group B did not show a statistically sig-
nificant mosaic signal of non-reticulate evolution, but 3SEQ’s
Dm,n,2 statistic for these two candidate recombinants showed
the greatest support for mosaicism possible among the
ancestry-informative polymorphic sites with their closest neigh-
bors by genetic similarity as parentals (n = 6, m = 42, k = 42). The
associated uncorrected p value of 5.7e-7 does not survive amul-
tiple comparisons correction due to the number of putative
parental lineages and descendants that were tested (Table 2)
The Dunn-Sidak correction used in 3SEQ is very conservative,
as it assumes that all 64.0 million comparisons we performed are
independent statistical tests, when in fact these tests are highly
nonindependent, since many candidate parental sequences are
a small number of nucleotide differences apart from each other.
When corrected p values are borderline, the recommended
approach to infer reticulate evolution is to build separate phylo-
genetic trees for the nonrecombining regions of the genome to
confirm that the recombinant in question has different phyloge-
netic placements in different genomic regions (Boni et al.,
2010). With the exception of the inner region for CAMC-5182 Cell 184, 5179–5188, September 30, 2021CB7AB3, whose placement within B.1.177 was not well sup-
ported, each recombinant’s two phylogenetic placements were
with the lineages that we identified as parental by genetic similar-
ity and by using 3SEQ, with high bootstrap support (Table S3).
The placement of the two parental genome regions for each re-
combinant in the context of the whole epidemic in the UK is
shown in Figure 3.
The mosaic structures of the genomes of the putative re-
combinants are shown in Figure 4. In six out of eight instances
(and all four of the groups of >1 sequence, which may represent
community transmission), the recombinants contain a spike
gene from the B.1.1.7 lineage. In four instances, there is a pro-
posed recombination breakpoint at or near the 50 end of the
spike gene.
Further evidence for the community transmission of
group A
A follow-up investigation of the eight sets of putative recombi-
nants (groups A–D and the four singletons) on May 5, 2021
found 41 sequences that were descended from group A (Fig-
ure 5). No descendants from any other recombinant event
were detected to have continued to circulate. The 41 se-
quences share the same set of SNPs with three members of
group A (ALDP-11CF93B, ALDP-125C4D7, and LIVE-DFCFFE),
with additional nucleotide variation at positions 8,090, 16,260,
and 25,521 (Figures 5A and S4). They were sampled in North
West England between March 1, 2021 and April 4, 2021 (Fig-
ures 5B and 5C). The temporal distribution of samples de-
scended from the recombination event that led to group A
suggests that the recombinant lineage persisted at low fre-
quency for a period of time before expanding and then con-
tracting again (Figure 5C). A second follow-up investigation
on July 14, 2021 found no further recombinants descended
from group A, which suggests that this transmission cluster is
extinct. The dynamics of this cluster of infections reflect the
wider trend of SARS-CoV-2 prevalence in England over the
same time period. Prevalence decreased from a maximum of
2.08% in January 2021 to 0.21% for the week beginning April
4, 2021 and to < 0.1% as of the beginning of May 2021 (Steel
and Hill, 2021). Group A and its descendants met the criteria for
designation as a recombinant Pango lineage (Pybus, 2021)
Table 2. Recombinants, their putative second parental lineages, and inferred breakpoints according to 3SEQ
Second parent lineage Uncorrected p value Corrected p value Breakpoint coordinatesa
Group A B.1.177 5E-13 (1E-12)b 0.00003 (0.00006)b 21,255–21,613 (18,998–20,294)b
Group Bc 5.70E-07 1 6,528–6,953
Group C B.1.221.1 4.26E-10 0.02686 25,996–27,441
Group D B.1.36.39 3E-12 0.0002 20,703–23,062
CAMC-CBA018 B.1.177 2E-12 0.00014 20,389–21,254
CAMC-CB7AB3 B.1.177 1E-11 0.00065 3,267–4,474 and 20,389–21,254
MILK-103C712 B.1.177.17 1.06E-10 0.00673 408–444 and 26,801–27,876
QEUH-1067DEF B.1.177.9 4.12E-10 0.026 10523 – 10869
The first parental lineage is always B.1.1.7. p values for the Dm,n,2 statistic are reported uncorrected and after Dunn-Sidak correction for multiple
comparisons.
aThe breakpoint coordinates reported by 3SEQ are the positions of spaces between nucleotides.
bFor group A, the results for LIVE-DFCFFE (in parentheses) were different from those of the rest of the group.
cStatistics are from a separate run with the closest neighbors by genetic similarity included in the parental dataset.
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OPEN ACCESSArticleand have been named lineage XA (https://cov-lineages.org/
lineages/lineage_XA.html).
DISCUSSION
Here, we report the first unambiguous detection and character-
ization of the arisal and subsequent community transmission
of recombinant SARS-CoV-2 viruses. Comparison of intra-
genomic variation, supported by geographic and epidemiolog-
ical data, demonstrates the occurrence of multiple independent
recombination events involving UK virus lineages in late 2020.
Recombinant genomes that share genetic identity were
sampled from the same geographic location and time period,
indicating they represent successful onward transmission after
the occurrence of a single ancestral recombination event. In
one instance, this resulted in a significant transmission cluster
comprising 45 observed cases, which has been given the
Pango lineage name XA. While no obvious biological advantage
can be attributed to this cluster (or any of the observed re-
combinants) beyond the acquisition of B.1.1.7’s set of spike
mutations, these recombinants are sentinel events for
continued monitoring for new variants. With the increasing co-
circulation of VOCs in the same geographic areas, careful moni-
toring is warranted.
Large-scale bioinformatic approaches have identified statisti-
cal signals of recombination among SARS-CoV-2 sequences us-
ing clade assignment and its changes along the genome as the
primary characteristic under investigation (Varabyou et al.,
2020; VanInsberghe et al., 2021). Due to the limited genetic di-
versity at the time these analyses were carried out, there was
no strong statistical support for recombination (as opposed to
non-reticulate diversification) for any particular candidate re-
combinant. When the number of mutations in a virus sequence
is low (e.g., Figure 3 in VanInsberghe et al., 2021 and Figure 2
in Varabyou et al., 2020), there is generally little statistical sup-
port to reject the possibility that the sequence patterns could
have been generated by mutation alone. In contrast, there is suf-
ficient diversity in the UK virus dataset between the lineage
B.1.1.7 and other co-circulating lineages to detect putative re-
combinants and demonstrate statistical significance for theirbreakpoint patterns. Candidate recombinants and their parental
lineages are a median of 22.5-nt mutations apart, and candidate
pairs of parentals are a median of 46-nt differences apart from
each other (Figures 2 and S2). The p values we present are exact
non-parametric probabilities that the observed patterns of
nucleotide ancestry in the candidate recombinant viruses were
generated by mutation alone given the parental genotypes and
are corrected for multiple testing.
The breakpoint locations inferred from the recombinants’
parental lineages by two different methods and two different
parental datasets are in agreement (cf. Tables 1 and 2). Two
interesting observations arise from their distribution. First, in
six cases, and in all the cases where we detected transmission,
the spike gene was inherited from the B.1.1.7 parental sequence
(Figure 4). This is consistent with the observed transmission
advantage of B.1.1.7 (Volz et al., 2021), which is likely attribut-
able to the mutations it carries in the spike region (Rambaut
et al., 2020b). Second, in four instances, a breakpoint is located
near the 50 end of the spike gene. A defining feature of the order
Nidovirales, to which coronaviruses belong, is the production
during RNA synthesis of a set of nested positive- and negative-
stranded subgenomic RNAs (sgRNAs) that contain a leader
sequence derived from the 50 end of the complete genome and
a progressively reduced complement of the structural (S, E, M,
N) and accessory genes, which form the body of the sgRNA
molecule (Masters, 2006; Kim et al., 2020). The discontinuous
nature of these sgRNAs is understood to be the product of tem-
plate switching by viral polymerase during normal transcription,
where the polymerase pauses at a transcription-regulatory
sequence (TRS) after transcribing the last open reading frame
(ORF) of the sgRNA and switches to a similar TRS upstream of
the leader sequence (Sawicki and Sawicki, 1995), omitting a
looped-out region of the template RNA, which contains at least
orf1ab in the case of SARS-CoV-2 (Finkel et al., 2021). This pro-
vides an environment that is highly conducive to homologous
recombination, including a polymerase that engages in template
switching during its normal transcriptional activity and the avail-
ability of alternative template RNA molecules, in the form of
sgRNAs, which incorporate sequence motifs that mediate tem-
plate switching and might be derived from different genomesCell 184, 5179–5188, September 30, 2021 5183
Figure 3. Phylogenetic placement of puta-
tive recombinant genome regions
Phylogenetic reconstruction of 2,000 samples
chosen to be representative of the course of the
epidemic in the UK, as well as the 16 recombinant
genomes, with their B.1.1.7-like part (colored tri-
angles) and non-B.1.1.7-like part (colored circles)
alternately unmasked. The tree is scaled by ge-
netic divergence, and the scale in numbers of
nucleotide changes is given in the bottom right of
the Figure.
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ORFs (Kim et al., 2020), are important in mediating template
switching during homologous recombination in coronaviruses,
this can account for the shared pattern of recombination-prone
regions observed here (Figure 4). However, to be detected, re-
combinant genomes must lead to viable viruses, so the distribu-
tion of breakpoints observed from genomic surveillance may not
represent the distribution of breakpoints that occur in situ (Ban-
ner and Lai, 1991).5184 Cell 184, 5179–5188, September 30, 2021Given the overall prevalence of
SARS-CoV-2 in the UK in December
2020 of 1% (Steel and Hill, 2021) and
assuming that 40% of infections were
of lineage B.1.1.7 and 40% of B.1.177
(Figure 1), a simplistic expectation for
the number of coinfections involving
these two lineages is the product of
their prevalences, which is 16 coinfec-
tions per million people. The figure
is 70 coinfections per million people
for a prevalence of 2%, 70% infection
with B.1.1.7, and 25% infection with
B.1.177, which applies to the first half
of January 2021. In this calculation, we
assume that infections are independent
and that once infected, the chance of
an additional infection occurring is un-
changed. This illustrates that on a na-
tional scale, coinfection should be quite
common during periods of high preva-
lence. From a public health perspective,
this reminds us that halving prevalence
reduces the chance of coinfection by a
factor of four, because the probability
of coinfection increases with the square
of the prevalence.
As recombination permits the combi-
nation of advantageous mutations from
distinct variants and recombination is
only possible with coinfection, minimizing
the prevalence of SARS-CoV-2 will mini-
mize the chance of forming recombinant
lineages with genetic combinations that
could potentially increase virus fitness.
At the time of writing, the trajectoryof the SARS-CoV-2 pandemic continues to remind us that there
are many populations worldwide still highly susceptible to
large epidemic waves. High-prevalence epidemic waves
comprising diverse viral lineages risk high rates of meaningful
recombination, and as SARS-CoV-2 genetic diversity is much
greater in 2021 than in 2020, it will be important to examine
each epidemic for the presence of novel recombinant lineages,
especially epidemics occurring in regions with circulation of
different variants of biological significance.
Figure 4. Mosaicism of putative recombinants
Recombinant groups A–D containmultiple sequences exhibiting the samemosaic genome structures (see Table 1 for details). Tractsmatching lineage B.1.1.7 are
shown in blue, while virus genome regions matching other lineages are shown in yellow. Gaps represent ambiguity in the exact position of the recombinant
breakpoints; there are no lineage-defining mutations within these regions. The breakpoint coordinates are taken from Table 1.
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In the Results, we discuss the possibility that the mosaic pat-
terns of genetic variation observed in the putative recombinant
genome sequences might be the product of some process other
than recombination, for example the sequencing of a natural co-
infection or of a mixed sample due to laboratory contamination.
However, neither the distribution of the raw read allele fre-
quencies for the putative recombinants (which are unlike those
we observe in samples that we suspect to be real mixtures)
nor the spatial distribution of genetic variation along their ge-
nomes (consisting of long contiguous tracts compatible with a
single lineage, which is not the pattern expected for a mixture
of samples given the sequencing protocol employed in the
UK) suggests that this is the case. In the case of the groups
A–D, the sequencing of multiple distinct samples with nearly
identical genetic variation provides strong a posteriori evidence
against any of these genomes being the product of sequencing
a mixed sample. This strength of evidence does not exist for the
four singleton genomes, so they should be viewed as less
certainly recombinant.STAR+METHODS
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Figure 5. The community transmission of group A
(A) The phylogenetic relationships between the closest genetic neighbors of group A for the B.1.1.7-inherited region of their genome (top clade; left-hand tree) and
the B.1.177-inherited region of their genome (bottom clade; left-hand tree), with branch lengths scaled by time. The sample date in cumulative epidemiological
weeks (epiweeks) since the first epiweek of 2020 for each sequence is also represented by colored circles at the tips of each tree; see the key for this scale. The
closest two parental sequences by genetic similarity for the two regions of the genomes (ALDP-12A277F and ALDP-119C5F7) are labeled in the left-hand tree,
and their tips are highlighted by black rings. The phylogenetic relationships within group A (top four taxa) and their descendants (bottom 41 taxa) are shown in the
right-hand tree, with branch lengths scaled by divergence. The dashed lines represent the formation of a new recombinant clade between the members of group
A and their parental lineages.
(B) The geographic context of the transmitted recombinant sequences. The exploded region of the map is the North-West region of England. All of the 41 re-
combinants descended from group A were sampled in this region. The relative distribution of their locations, in the same scale as the exploded region, are
represented by the circles in the red dashed square. The size of the points represents the number of genomes sequenced in each location. The absolute locations
of the recombinants within North West England are not represented by this panel.
(C) The distribution of the sampling dates for the 45 recombinants, aggregated by epiweek. Orange bars, four original members of group A; green bars, 41
descendants from group A.
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METHOD DETAILS
Identification of putative recombinants
A national SARS-CoV-2 sequencing effort in the UK, the COG-UK consortium (COVID-19 Genomics UK (COG-UK (COVID-19
Genomics UK), 2020), has undertaken systematic genomic surveillance of SARS-CoV-2 in the country and generated over
440,000 genomes to date. As part of the COG-UK daily analytical pipeline (https://github.com/COG-UK/datapipe), the consensus
genome sequences of the complete set of UK samples were aligned to the SARS-CoV-2 reference sequence (GenBank:
MN908947.3) using Minimap2 (Li, 2018). The aligned sequences were converted from sam to fasta format, and each assigned a
Pango lineage (Rambaut et al., 2020a) using Pangolin (O’Toole et al., 2021). Pango lineages are designed to capture ongoing epide-
miological trends at a resolution suitable for genomic epidemiology and outbreak investigation (Rambaut et al., 2020a). From the
sequence alignment, we extracted all sequences that had been assigned to lineage B.1.1.7, up to the 2021/03/07. We genotyped
these sequences at the set of 22 sites that discriminate B.1.1.7 from its parental lineage (B.1.1) using a custom script in Python
(https://github.com/cov-ert/type_variants), then discarded sequences with missing data at any of the 22 sites. We visualized the re-
sulting table of genotype calls in order to identify sequences that showed evidence of a potential mosaic genome structure (i.e., runs
of contiguous sites that were not compatible with the B.1.1.7 lineage designation).
Identification of candidate parental sequences
To identify candidate parental genome sequences in a computationally-tractable manner we created a set of all UK SARS-CoV-2
sequences that (i) contained no N nucleotide ambiguity codes after masking the 30 and 50 UTRs, (ii) spanned the dates 2020/12/
01 to 2021/02/28, which represents two weeks before the date of the earliest putative recombinant, to one week after the date of
the latest, and (iii) excluded the putative recombinant genomes identified above. This set consisted of 98859 sequences in total.
For each putative recombinant, we split its genome sequence into B.1.1.7-like regions and non-B.1.1.7 regions at the junction of ge-
netic regions according to the mosaic structure detected by the custom Python script described above (https://github.com/cov-ert/Cell 184, 5179–5188.e1–e3, September 30, 2021 e1
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with Ns (in both the focal mosaic sequence and all background sequences) then found the most-genetically similar non-focal se-
quences by computing pairwise genetic distances (number of nucleotide differences per site) using gofasta (https://github.com/
cov-ert/gofasta). Subsequently, an alignment was compiled for each putative recombinant, which contained the putative recombi-
nant as well as the most-genetically similar background sequences (as identified above) for each component region of that mosaic
genome. The single nucleotide differences between the putative recombinant and the closely related reference sequenceswere visu-
alized using snipit (https://github.com/aineniamh/snipit). The genomic coordinates of the boundaries between each mosaic genome
region were then refined by taking into account observed lineage-defining nucleotide and deletion variation. Specifically, we set the
boundary coordinates to the ends of sequential tracts of mutations specific to the putative parental sequences. This is a conservative
approach to assigning parental lineages and consequently no parental lineage is assigned to those genome regions that do not
contain unambiguous lineage-defining mutations or deletions. Lastly, using these refined region boundaries, we reiterated the ge-
netic distance calculation above to identify a final set of most-genetically similar sequences for each putative recombinant.
When reporting geographic locations for UK virus genome sequences we use level 1 of the Nomenclature of Territorial Units for
Statistics (NUTS) geocode standard (https://ec.europa.eu/eurostat/web/nuts/history).
Defining a representative sample from the UK epidemic
To generate a limited set of genomes that are suitable for computationally-expensive analysis yet are also representative of the ge-
netic diversity of the SARS-CoV-2 epidemic in theUK,we randomly sampled 2000 sequences from 21stMarch 2020, when sequence
data first became available, to 1st March 2021, weighting the probability of choosing a sequence accounting for the sequencing
coverage and covid19 prevalence in individual geographic regions of the UK over time, using the same method as in Volz et al.
(2021), which is available at (https://github.com/robj411/sequencing_coverage). We use this dataset to investigate the phylogenetic
placement of the alternate regions of recombinant genomes, and as a dataset of putative parental sequences to statistically test for
recombination using 3SEQ.
Investigation of read data
Almost all sequencing sites in the COG-UK consortium use the ARTIC PCR protocol to produce tiled PCR amplicons, which are then
sequenced (Tyson et al., 2020). The generated sequence reads are then processed using sequence mapping, rather than sequence
assembly, to produce a consensus genome for each sample. This approach, which was designed to support epidemiological inves-
tigations, creates a single consensus sequence for each sample. Beyond representing sites with high minor allele frequencies using
the appropriate IUPAC nucleotide alphabet ambiguity code, this consensus does not reflect the natural genetic variation of SARS-
CoV-2 genomes observed within an infected individual (Lythgoe et al., 2021). Mapping is particularly suited to tiled amplicons gener-
ated from samples that contain limited genomic diversity. Further, mapping is typically less prone to introducing errors/artifacts than
sequence assembly and enables effective primer sequence removal and identification of non-reference mutations. Genomic sites
that exhibit intra-sample nucleotide variation could be consistent with a range of processes, including co-infection, within-patient
diversity, contamination, or PCR error. The identification of such sites forms part of the consensus-generating pipeline, and we
exploit that information here in order to rule out the possibility that our mosaic consensus sequence represents a mixture of virus
genomes, rather than representing true recombinant genomes.
For each putative recombinant sequencewe analyzed the original read data from virus genome sequencing in order to rule out the pos-
sibility that the generated consensus sequence represents amixture of virus genomes (due to laboratory contamination or coinfection, for
example), rather than representinga true recombinantgenome.Todo thiswecalculatedminorallele frequencies (MAFs) fromthe readdata
and compared their distribution between the 16 recombinant genomes and 20 samples that we suspected of being the product of
sequencingamixtureof genomes,potentially becauseof coinfectionor laboratory contamination. Todefinesequences thatwesuspected
ofbeingmixtures,wescanned thedataset forconsensussequences thatpossessedan IUPACambiguitycodeat the27genomicpositions
that differ from the SARS-CoV-2 reference genome (GenBank: MN908947.3) by a nucleotide change in B.1.1.7 (the 27 positions include
those with nucleotide changes that were inherited from the ancestor of B.1.1.7). We define the MAF at a single site as the number of
sequencing readsnot containing themost frequently observedsinglenucleotideallele thatmapped to that site, dividedby the total number
of sequencing reads that include any nucleotide allele that mapped to that site. For each virus genome, we defined a set of genomic po-
sitions fromwhich to calculateMAFas follows. For each recombinant,weconsidered every site that differed fromMN908947.3by anucle-
otide in its own consensus genome, or in the consensus genome of either of its parentals by genetic similarity. For the sequences that we
suspected of beingmixtureswe considered the 27 genomic positionswhere sequencesbelonging toB.1.1.7 differ fromMN908947.3 by a
nucleotide change.We used samtools (Li et al., 2009), with default filters for mapping and base quality, to extract allele calls from the read
data using its mpileup subroutine, and to calculate mean read depth per genome using its depth subroutine.
QUANTIFICATION AND STATISTICAL ANALYSIS
Test for mosaic genome structure
We used 3SEQ (Lam et al., 2018) as a statistical test for recombination in the UK SARS-CoV-2 data. 3SEQ interrogates triplets of
sequences for a signal of mosaicism in one ‘‘child’’ sequence, given the genotypes of the other two ‘‘parental’’ sequences, usinge2 Cell 184, 5179–5188.e1–e3, September 30, 2021
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simply tests if a putative recombinant’s ancestry in parental A clusters in the middle of the genome, while ancestry in parental B clus-
ters in the outer regions of the genome. Wemanually adjusted two-breakpoint recombinants to be single-breakpoint recombinants if
one of the breakpoints according to 3SEQ abutted the beginning or end of the genome. We tested all potential pairs of sequences
from the representative parental dataset from the course of the UK pandemic (n = 2000) against each putative recombinant in the
child dataset (n = 16), and report p values that are uncorrected and that are Dunn-Sidak corrected for multiple comparisons (n =
64.0 million). We performed a single additional run of 3SEQ with two putative recombinant sequences that were not found to be
significantly the mosaic product of any of the sequences in the representative background as children, and their closest neighbors
by genetic similarity as parentals. P values for this test were reported without correction and after correction for multiple testing
assuming that this test was in addition to the 64 million comparisons that we had already performed. The input and output files
for the 3SEQ analysis are available at https://github.com/COG-UK/UK-recombination-analysis.
Test for the phylogenetic incongruence of putative recombinant genome tracts
For each of the eight sets of recombinants (Groups A-D and the four singletons) we carried out the following procedure to test for
incongruence between the phylogenetic placements of the two regions of their genomes. We independently added each set’s ge-
nome(s) to the representative background of 2000 sequences, along with the reference sequence, to create eight alignments in total.
We masked the resulting alignments according to the breakpoints defined by the closest neighbors by genetic similarity, so that for
each set, we produced two sub-alignments: one consisting of the region that was inherited from the B.1.1.7 parental in the recombi-
nant(s), and one consisting of the region that was inherited from the other parental. This resulted in 16 alignments in total. We recon-
structed the phylogenetic relationships for each with IQTREE v2.1 (Minh et al., 2020), using the HKYmodel of nucleotide substitution,
conducting 1000 ultrafast bootstrap replicates (Minh et al., 2013; Hoang et al., 2018), and rooting the tree on the reference sequence,
which is basal to all B lineage sequences. The phylogenetic trees produced by this analysis are available at https://github.com/
COG-UK/UK-recombination-analysis.
To determine the placement of the different regions of each recombinant genome in a single context, we also built a phylogenetic
tree of the representative background’s complete genomes, to which we added the masked recombinant genomes, so that each
recombinant was present in the alignment twice, once with the B.1.1.7 region of its genome unmasked, and once with the opposing
region unmasked. We ran IQTREE as above.
Follow up of putative recombinants
To test for onward community transmission of the putative recombinants, we searched the whole UK dataset as of the 5th May 2021
for additional sequences whose genetic variation matched the variation of the recombinants. For each of the eight set of recombi-
nants, we defined a set of SNPs and deletions by which all the recombinants within that set differed from the reference sequence
(MN908947.3). Then we used type_variants to scan the UK dataset for genomes whose SNP and deletion variation was compatible
with being a descendant or sibling of the putative recombinants. Group A represented the only recombination event with evidence for
further transmission according to the results of this procedure. We carried out the following additional analyses to further investigate
transmission of Group A genomes. First, we visualized the nucleotide variation of the additional matching genomes using snipit and
extracted their sampling locations and dates. Second, to explore the phylogenetic context of Group A and its derivatives, we recon-
structed their (whole-genome) phylogenetic relationships using IQTREE. We also extracted the 100 closest sequences by genetic
similarity for each alternate region of the genome (B.1.1.7-like and non-B.1.1.7-like) for each of the four original members of Group
A to provide phylogenetic context to the parental sequences. This resulted in a dataset of 216 sequences in total when the two groups
of neighbors were combined, and duplicates removed. We reconstructed their (whole-genome) phylogenetic relationships with the
IQTREE, as above. We generated a time-scaled phylogenetic tree from the divergence tree of parental sequences using TreeTime
(Sagulenko et al., 2018), setting the–clock-rate parameter to 0.001. We labeled the phylogenetic tree of recombinants and the phylo-
genetic tree of parental sequences with the sampling date in number of epidemiological weeks (epiweeks) since the first epiweek of
2020 to assess the temporal context of the recombination event and subsequent transmission. We carried out a second follow up on
14th July 2021 using the same procedure as above.Cell 184, 5179–5188.e1–e3, September 30, 2021 e3
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Figure S1. Read data minor allele frequencies, related to STAR Methods
The distribution of minor allele frequencies from the read data for the 16 putative recombinants (red bars) and 20 samples suspected of being sequenced
mixtures, either due to co-infection or laboratory contamination (gray bars). For each recombinant, theminor allele frequency is themean across all sites that differ
by a nucleotide change from the reference (MN908947.3) in it or either of its putative parentals by genetic similarity. For the mixtures, the minor allele frequency is
the mean across the sites that differ by a nucleotide change from the reference at genomic positions where mutations occur in B.1.1.7.
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Figure S2. The nucleotide variation present in the recombinants and their parentals, related to Figure 2
The nucleotide variation with respect to the reference sequence (MN908947.3; gray genome far bottom) for each of the recombinant genomes (middle colored
genomes in each panel) and their closest neighbors by genetic similarity among all UK sequences from the same time period, for the B.1.1.7-like and non-B.1.1.7-










Figure S3. SARS-CoV-2 lineages in geographic regions of the UK relevant to the recombinants, related to Figure 1
The distribution of the most frequent SARS-CoV-2 lineages in the NUTS1 location of each set (Groups A-D and the four singletons) of recombinants for the four




Figure S4. The nucleotide variation present in the descendants of group A, related to Figure 5
The distribution of nucleotide variation in the original members of group A (top four colored rows) and the 41 additional sequences that are derived from it (bottom
41 colored rows), with respect to the reference sequence (MN908947.3; very bottom gray sequence).
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